The study tested ivonescimab, an innovative bispecific antibody, combining it with platinum-doublet chemotherapy in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback